Community Readiness Challenge

The Community Readiness Challenge encourages individuals and families to build a pandemic preparedness kit by providing detailed lists of weekly items to buy and ways to prepare for 26 weeks. The LOCC box portion of the program uses business donations to assemble personal preparedness kits for economically-disadvantaged citizens. This practice is noteworthy, because it addresses a group for which there is little focus on prevention and planning efforts. It may benefit from being combined with other practices that address the needs of disadvantaged citizens, although it is a straightforward approach to personal preparedness that could be replicated in most community or local agencies.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Ilmuwan Uji Obat Covid-19 Baru yang Minim Efek Samping Berbahaya thumbnail

Ilmuwan Uji Obat Covid-19 Baru yang Minim Efek Samping Berbahaya

PARA ilmuwan di Central Drug Research Institute (CDRI) di Lucknow sedang mencoba mengembangkan obat Covid-19 tanpa efek samping. Sebuah tim yang dipimpin oleh kepala ilmuwan Ravi Shankar, saat ini sedang mengerjakan dua kombinasi untuk menyediakan obat teraman bagi pasien virus corona. “Para ahli mengatakan bahwa kombinasi antivirus dengan mekanisme yang berbeda dapat lebih efektif untuk…
Read More
Adding Docetaxel to RT Improves Survival in Cisplatin-Ineligible Head & Neck Cancer thumbnail

Adding Docetaxel to RT Improves Survival in Cisplatin-Ineligible Head & Neck Cancer

Oncology/Hematology > Other Cancers — Options needed since it is not uncommon to encounter cisplatin ineligibility, researchers say by Mike Bassett, Staff Writer, MedPage Today February 3, 2023 Adding docetaxel to radiation therapy (RT) improved survival outcomes in cisplatin-ineligible patients with locally advanced head and neck squamous cell carcinoma, a phase III randomized trial showed.
Read More
Enzalutamide Rechallenge Yields Small PFS Boost in Metastatic Prostate Cancer thumbnail

Enzalutamide Rechallenge Yields Small PFS Boost in Metastatic Prostate Cancer

In patients with metastatic castration-resistant prostate cancer (CRPC) who have progressed on enzalutamide (Xtandi), those who continued the treatment in combination with docetaxel and prednisolone saw improved progression-free survival (PFS), the phase IIIb PRESIDE study found. Median PFS was 9.53 months with the the enzalutamide-based combination compared with 8.28 months in those treated with placebo…
Read More
Dupilumab Effective for Up To 1 Year in Teens With AD: Study thumbnail

Dupilumab Effective for Up To 1 Year in Teens With AD: Study

Serious adverse events remained rare and skin remained largely clear in adolescents treated with dupilumab (Dupixent) for moderate-to-severe atopic dermatitis (AD) for up to 52 weeks in a phase 3 open-label extension trial, researchers reported. At 1 year, 86% of 50 remaining patients with weights under 60 kg (132 lb) had achieved 75% improvement (EASI-75;…
Read More
Weekly Check-up: Influenza increase in Southeast Brazil, cardiovascular health and more!  [podcast] thumbnail

Weekly Check-up: Influenza increase in Southeast Brazil, cardiovascular health and more! [podcast]

Avalie o nosso conteúdo: Houve um erro fazendo sua requisição, por favor tente novamente! Obrigado!Sua avaliação é fundamental para que a gente continue melhorando o Portal Pebmed O Portal PEBMED é destinado para médicos e demais profissionais de saúde. Nossos conteúdos informam panoramas recentes da medicina. Caso tenha interesse em divulgar seu currículo na internet,…
Read More
Index Of News
Consider making some contribution to keep us going. We are donation based team who works to bring the best content to the readers. Every donation matters.
Donate Now

Subscription Form

Liking our Index Of News so far? Would you like to subscribe to receive news updates daily?

Total
0
Share